MAP3K5-AS1

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, MAP3K5-AS1 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated MAP3K5-AS1 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher MAP3K5-AS1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MAP3K5-AS1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUSC show a favorable association.

HNSC, KIRC, and LUAD are the cancer types where MAP3K5-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
HNSCDFSTertileAll0.7570.621<.001139view →
KIRCOSMedianAll0.5780.733<.00164view →
LUADDFSMedianAll0.5460.748<.00151view →
LUSCOSTertileIII,IV0.6890.414.00439view →
SKCMOSMedianIV0.8940.292<.00130view →
GBMOSTertileAll0.3070.452.01421view →
CHOLOSTertileII,III,IV0.0800.740.02618view →
LGGOSMedianAll0.9780.834<.00115view →
KIRPOSMedianAll0.5140.883.01510view →
TGCTDFSMedianAll0.9090.753.00510view →
DLBCDFSMedianII,III,IV0.6530.956.0099view →
ACCOSTertileIV0.4050.886.0246view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

MAP3K5-AS1–HNSC (DFS)

Kaplan–Meier survival curve for MAP3K5-AS1 RNA-high vs -low samples in HNSC.

Open the HNSC breakdown →

Exploration